Treatment of Fibromyalgia With Recovery Factors

NCT ID: NCT04381780

Last Updated: 2021-10-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

100 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-06

Study Completion Date

2021-01-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Treatment of Fibromyalgia and CFS with Recovery Factors

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Use of a unique oral porcine peptide nutritional supplement in those meeting ACR 2010(amended) diagnostic criteria for Fibromyalgia or CDC Criteria for CFS

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Fibromyalgia Chronic Fatigue Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Open pilot study
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Assessing clinical outcomes

Nutritional support with Recovery Factors

Group Type EXPERIMENTAL

Recovery Factors

Intervention Type DIETARY_SUPPLEMENT

A unique porcine serum based polypeptide nutritional support

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Recovery Factors

A unique porcine serum based polypeptide nutritional support

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Meet the ACR 2010 Amended Fibromyalgia Diagnostic Criteria or CFS CDC criteria; Score 5 or less on Energy VAS

Exclusion Criteria

Under 18 Pregnant Other severe complicating conditions

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Practitioners Alliance Network

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jacob Teitelbaum MD

Kailua, Hawaii, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

PAN Study RF-2- 2020

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Tailored Treatments of Fibromyalgia
NCT00000422 COMPLETED PHASE2/PHASE3
Pain Management Techniques for Fibromyalgia
NCT00086060 COMPLETED PHASE1/PHASE2
Neurophysiology of Fibromyalgia
NCT06006130 UNKNOWN NA